Related Experiment Video

Updated: Sep 21, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.5K

Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management

Lin Tong1,2, Shumin Huang1,2, Chen Zheng1,2

  • 1Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China.

Journal of Clinical Medicine
|May 28, 2022
PubMed

Insights

Refractory Mycoplasma pneumoniae pneumonia (RMPP) is a severe infection. Early detection and combined therapies are key to improving outcomes for this challenging condition.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Immunology

Background:

  • Refractory Mycoplasma pneumoniae pneumonia (RMPP) is an increasingly recognized severe clinical condition.
  • The exact pathogenesis of RMPP is not fully understood.
  • Potential contributing factors include exaggerated host immune responses and macrolide resistance in M. pneumoniae.

Purpose of the Study:

  • To highlight the importance of early recognition of RMPP.
  • To identify potential diagnostic clues for RMPP.
  • To outline current therapeutic strategies for RMPP.

Main Methods:

  • This study is a review of current understanding and clinical observations regarding RMPP.
  • It synthesizes information on pathogenesis, diagnosis, and treatment.

Main Results:

  • Early identification of RMPP is crucial for better patient prognosis.
  • Key indicators for RMPP may include macrolide-resistant M. pneumoniae detection, lack of clinical response to macrolides, and elevated pro-inflammatory cytokines.
  • Effective treatment involves a combination of anti-mycoplasmal and immunomodulating therapies.

Conclusions:

  • Prompt diagnosis and appropriate management are essential for treating refractory Mycoplasma pneumoniae pneumonia.
  • A dual approach combining antimicrobial and immunomodulatory treatments offers the most promising strategy for improving patient outcomes.
Keywords:
Mycoplasma pneumoniaepneumoniapredictiontreatment

More Related Videos

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

544
A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice07:43

A Non-invasive and Technically Non-intensive Method for Induction and Phenotyping of Experimental Bacterial Pneumonia in Mice

Published on: September 28, 2016

9.2K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
463
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
460
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
350
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
55
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
251